外科

Medicine & Life Sciences

1. Rectal Neoplasms 100%
2. Liver 73%
3. Robotics 54%
4. Colorectal Neoplasms 40%
5. Neoplasm Metastasis 36%
6. Neoplasms 33%
7. Drug Therapy 32%
8. Intra Arterial Infusions 30%
9. Lymph Node Excision 28%
10. Prolapse 28%
11. Colostomy 28%
12. Swine 27%
13. Iliac Artery 26%
14. Perfusion 26%
15. Recurrence 24%
16. Sigmoid Neoplasms 21%
17. Pelvis 21%
18. Hepatectomy 21%
19. degradable starch microspheres 20%
20. Hepatocellular Carcinoma 20%
21. Colonic Neoplasms 20%
22. Papio 20%
23. Laparoscopy 19%
24. Cross Circulation 18%
25. polysaccharide-K 18%
26. Rectovaginal Fistula 17%
27. Ascending Colon 17%
28. Retroviridae Infections 17%
29. Solitary Fibrous Tumors 16%
30. Cystic Lymphangioma 16%
31. Colectomy 16%
32. Fluorouracil 16%
33. Intestinal Pseudo-Obstruction 16%
34. Equipment and Supplies 16%
35. Lymphangioma 16%
36. Endogenous Retroviruses 15%
37. Japan 15%
38. Bacterial Translocation 15%
39. Restorative Proctocolectomy 15%
40. Carcinoma 15%
41. Acute Necrotizing Pancreatitis 15%
42. Lymph Nodes 15%
43. Alprostadil 15%
44. Therapeutics 15%
45. Proctectomy 14%
46. Interleukin-2 14%
47. Anastomotic Leak 13%
48. Irinotecan 13%
49. Acute Liver Failure 13%
50. Loss of Heterozygosity 13%
51. Ulcerative Colitis 13%
52. Mitomycin 12%
53. Propensity Score 12%
54. Chemoradiotherapy 12%
55. Computed Tomography Angiography 12%
56. Hemolysis 12%
57. Stomach Neoplasms 12%
58. Gastrectomy 12%
59. T-Cell Antigen Receptor 11%
60. Necrosis 11%
61. Primates 11%
62. Hepatitis B virus 11%
63. Portal Vein 11%
64. Colon 10%
65. Leucovorin 10%
66. Laparotomy 10%
67. Cisplatin 10%
68. Abdominal Cavity 10%
69. Ligation 10%
70. Canidae 10%
71. Radiotherapy 10%
72. Cohort Studies 9%
73. Drainage 9%
74. Gases 9%
75. Hepatocytes 9%
76. Arteries 9%
77. Signal Transduction 9%
78. Cytokines 9%
79. Operative Time 9%
80. Catheter Obstruction 8%
81. Retrospective Studies 7%
82. Rectum 7%
83. Sigmoid Colon 7%
84. Adenocarcinoma 7%
85. Transverse Colon 7%
86. Veins 7%
87. T-Lymphocytes 7%
88. Survival Rate 7%
89. Length of Stay 7%
90. Abdominal Wall 6%
91. Morbidity 6%
92. Survival 6%
93. Blood Group Antigens 6%
94. Intercellular Adhesion Molecule-1 6%
95. Colonoscopy 5%
96. Pharmaceutical Preparations 5%
97. Femoral Artery 5%
98. Multiple Organ Failure 5%
99. Hemangiopericytoma 5%
100. Infertility 5%